We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.

Delisted

CSII was delisted on the 27th of April, 2023.

138 hedge funds and large institutions have $552M invested in Cardiovascular Systems, Inc. in 2016 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 38 increasing their positions, 34 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

283% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 12

123% more call options, than puts

Call options by funds: $958K | Put options by funds: $430K

33% more funds holding

Funds holding: 104138 (+34)

32% more capital invested

Capital invested by funds: $417M → $552M (+$135M)

12% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 34

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
138
Holders Change
+34
Holders Change %
+32.69%
% of All Funds
3.68%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
46
Increased
38
Reduced
34
Closed
12
Calls
$958K
Puts
$430K
Net Calls
+$528K
Net Calls Change
+$285K
Name Holding Trade Value Shares
Change
Change in
Stake
California State Teachers Retirement System (CalSTRS)
51
California State Teachers Retirement System (CalSTRS)
California
$1.6M +$15.3K +700 +1%
Two Sigma Advisers
52
Two Sigma Advisers
New York
$1.44M +$1.33M +60,562 New
TA
53
Teachers Advisors
New York
$1.4M +$192K +8,755 +17%
HI
54
HBK Investments
Texas
$1.21M +$1.11M +50,900 New
AllianceBernstein
55
AllianceBernstein
Tennessee
$1.2M
MC
56
Menta Capital
California
$1.17M +$640K +29,217 +146%
Swiss National Bank
57
Swiss National Bank
Switzerland
$1.16M -$43.8K -2,000 -4%
Jacobs Levy Equity Management
58
Jacobs Levy Equity Management
New Jersey
$1.11M +$1.02M +46,808 New
EIM
59
Essex Investment Management
Massachusetts
$1.08M -$46.2K -2,112 -4%
GF
60
Gabelli Funds
New York
$1.02M
Acadian Asset Management
61
Acadian Asset Management
Massachusetts
$1.01M +$930K +42,459 New
Connor, Clark & Lunn Investment Management (CC&L)
62
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$950K +$652K +29,800 +292%
LCG
63
Lisanti Capital Growth
New York
$948K +$312K +14,255 +55%
GI
64
GAMCO Investors
Connecticut
$864K
GCP
65
GSA Capital Partners
United Kingdom
$832K +$299K +13,646 +64%
RhumbLine Advisers
66
RhumbLine Advisers
Massachusetts
$812K -$12.4K -565 -2%
SO
67
STRS Ohio
Ohio
$807K +$512K +23,400 +221%
New York State Common Retirement Fund
68
New York State Common Retirement Fund
New York
$783K +$56.9K +2,600 +9%
TC
69
TFS Capital
Pennsylvania
$781K +$721K +32,914 New
Jane Street
70
Jane Street
New York
$753K +$694K +31,718 New
EA
71
Emerald Acquisition
Washington
$741K +$683K +31,193 New
UBS Group
72
UBS Group
Switzerland
$738K +$42.3K +1,933 +7%
EMR
73
Errol M. Rudman
$712K +$657K +30,000 New
MAM
74
Meeder Asset Management
Ohio
$700K
SIM
75
Spark Investment Management
New York
$633K +$585K +26,700 New

CSII Hedge Fund Activity: Q3 2016 in Review

138 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q3 2016, worth a combined $552M — up 32% from $417M a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new CSII positions and 12 closed out — a net gain of 34 holders — while 38 added to existing stakes and 34 trimmed.

The largest buyer was PFM Health Sciences, opening a new position worth an estimated $11M. The largest seller was Camber Capital Management, cutting an estimated $24.1M.

  • 138 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q3 2016, up from 104 in Q2 2016.
  • Funds reported $552M of Cardiovascular Systems, Inc. stock for Q3 2016, up 32% quarter-over-quarter.
  • 46 funds opened new Cardiovascular Systems, Inc. positions in Q3 2016 and 12 closed out, a net change of +34 holders.
  • The largest Cardiovascular Systems, Inc. buyer in Q3 2016 was PFM Health Sciences, an estimated $11M added.
  • The largest Cardiovascular Systems, Inc. seller in Q3 2016 was Camber Capital Management, an estimated $24.1M sold.

Based on aggregated 13F filings for Q3 2016.